Skip to contentM
Marimed Inc.
M
MRMDMarimed Inc. Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$20.36M$20.36Mderived−40.5% vs Q4 2019 Net Income$4.12M$4.12MderivedN/M vs Q4 2019 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Marimed Inc. · CIK 1522767 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$11,618,828+313.0% Operating Incomederived$8,025,912N/M Operating Cash Flowderived$1,774,092+3,915.2% Free Cash Flowderived$1,202,350N/M Margins · derivedGross margin57.1%+48.9 pt vs Q4 2019
Operating margin39.4%+178.6 pt vs Q4 2019
Net margin20.2%+249.5 pt vs Q4 2019
ended Dec 31, 2020 · filed Mar 23, 2021 · 82 d after period end